NO20011162D0 - FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset - Google Patents

FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset

Info

Publication number
NO20011162D0
NO20011162D0 NO20011162A NO20011162A NO20011162D0 NO 20011162 D0 NO20011162 D0 NO 20011162D0 NO 20011162 A NO20011162 A NO 20011162A NO 20011162 A NO20011162 A NO 20011162A NO 20011162 D0 NO20011162 D0 NO 20011162D0
Authority
NO
Norway
Prior art keywords
modulating
preparations
interaction
methods
hiv virus
Prior art date
Application number
NO20011162A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011162L (no
Inventor
Robert Doms
Daryl Faulds
Joseph E Hesselgesser
Richard Horuk
Branislava Mitrovic
Yiqing Zhou
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20011162L publication Critical patent/NO20011162L/no
Publication of NO20011162D0 publication Critical patent/NO20011162D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20011162A 1998-09-08 2001-03-07 FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset NO20011162D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/149,045 US6475718B2 (en) 1998-09-08 1998-09-08 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus
PCT/EP1999/006553 WO2000014220A1 (en) 1998-09-08 1999-09-07 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus

Publications (2)

Publication Number Publication Date
NO20011162L NO20011162L (no) 2001-03-07
NO20011162D0 true NO20011162D0 (no) 2001-03-07

Family

ID=22528559

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011162A NO20011162D0 (no) 1998-09-08 2001-03-07 FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset

Country Status (14)

Country Link
US (5) US6475718B2 (ja)
EP (1) EP1109906A1 (ja)
JP (1) JP2002532061A (ja)
KR (1) KR20020013467A (ja)
AU (1) AU767484B2 (ja)
BR (1) BR9913635A (ja)
CA (1) CA2341782A1 (ja)
HU (1) HUP0103768A3 (ja)
IL (1) IL141452A0 (ja)
NO (1) NO20011162D0 (ja)
PL (1) PL346564A1 (ja)
RU (1) RU2225721C2 (ja)
SK (1) SK3082001A3 (ja)
WO (1) WO2000014220A1 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403447A1 (en) * 2000-03-23 2001-09-27 Takeda Chemical Industries, Ltd. Peptide derivative
AU2001264937A1 (en) * 2000-05-23 2001-12-03 Genaissance Pharmaceuticals, Inc. Haplotypes of the agtrl1 gene
WO2006023893A2 (en) * 2004-08-23 2006-03-02 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for modulating angiogenesis and apoptosis with apelin compositions
PL2708558T3 (pl) 2008-04-11 2018-09-28 Chugai Seiyaku Kabushiki Kaisha Cząsteczka wiążąca antygen zdolna do wiązania dwóch lub więcej cząsteczek antygenu w sposób powtarzalny
TWI440469B (zh) 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
SG10201509790YA (en) * 2010-11-30 2015-12-30 Chugai Pharmaceutical Co Ltd Antigen-Binding Molecule Capable Of Binding To Plurality Of Antigen Molecules Repeatedly
CN112812184A (zh) 2011-02-25 2021-05-18 中外制药株式会社 FcγRIIb特异性Fc抗体
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
TW201817745A (zh) 2011-09-30 2018-05-16 日商中外製藥股份有限公司 具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
US20150050269A1 (en) 2011-09-30 2015-02-19 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
JP6151269B2 (ja) * 2011-12-16 2017-06-21 カーギル・インコーポレイテッド 環境に優しい改善された融氷剤組成物
ES2708957T3 (es) 2013-03-14 2019-04-12 Regeneron Pharma Proteínas de fusión de apelina y usos de las mismas
CA2931299C (en) 2013-11-20 2024-03-05 Regeneron Pharmaceuticals, Inc. Aplnr modulators and uses thereof
CN107207607B (zh) 2014-12-19 2021-05-04 中外制药株式会社 抗-c5抗体及使用方法
BR112017006736A2 (pt) 2014-12-19 2017-12-19 Chugai Pharmaceutical Co Ltd anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes, e métodos de utilização
SG11201706014PA (en) 2015-02-05 2017-08-30 Chugai Pharmaceutical Co Ltd Antibodies comprising an ion concentration dependent antigen-binding domain, fc region variants, il-8-binding antibodies, and uses therof
TW202339800A (zh) 2015-02-27 2023-10-16 日商中外製藥股份有限公司 Il-6受體抗體用於製備醫藥組成物的用途
JP7141336B2 (ja) 2015-12-25 2022-09-22 中外製薬株式会社 抗ミオスタチン抗体および使用方法
CA3026050A1 (en) 2016-08-05 2018-02-08 Chugai Seiyaku Kabushiki Kaisha Composition for prophylaxis or treatment of il-8 related diseases
US11608374B2 (en) 2017-01-30 2023-03-21 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use
JP7185884B2 (ja) 2017-05-02 2022-12-08 国立研究開発法人国立精神・神経医療研究センター Ｉｌ－６及び好中球の関連する疾患の治療効果の予測及び判定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045543A2 (en) 1996-05-28 1997-12-04 The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health Cc chemokine receptor 5, antibodies thereto, transgenic animals
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same

Also Published As

Publication number Publication date
US20030008376A1 (en) 2003-01-09
JP2002532061A (ja) 2002-10-02
RU2225721C2 (ru) 2004-03-20
SK3082001A3 (en) 2001-09-11
US20030008391A1 (en) 2003-01-09
HUP0103768A3 (en) 2004-07-28
US20030008279A1 (en) 2003-01-09
US20020062488A1 (en) 2002-05-23
BR9913635A (pt) 2001-05-22
NO20011162L (no) 2001-03-07
HUP0103768A2 (hu) 2002-02-28
AU5973799A (en) 2000-03-27
WO2000014220A1 (en) 2000-03-16
CA2341782A1 (en) 2000-03-16
KR20020013467A (ko) 2002-02-20
IL141452A0 (en) 2002-03-10
AU767484B2 (en) 2003-11-13
PL346564A1 (en) 2002-02-11
US6475718B2 (en) 2002-11-05
US20030003447A1 (en) 2003-01-02
EP1109906A1 (en) 2001-06-27

Similar Documents

Publication Publication Date Title
NO20011162D0 (no) FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
NO20004104L (no) Preparater omfattende virus og fremgangsmater for konsentrering av viruspreparater
NO992736D0 (no) Ikke oppgitt
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
DE122012000017I1 (de) Neuartige form von s-omeprazol.
DE69630044D1 (de) Viren inaktivierende umhüllungen
EE03903B1 (et) Omeprasooli ravimvorm
NO965539D0 (no) Farmasöytiske tacrinepreparater
ID28258A (id) Metode dan aparatus untuk balok seimbang memperkuat sesitifitas
NO20003302D0 (no) Vaksine
NL1006622A1 (nl) Orthodontische inrichtingen.
DK1131301T3 (da) 2-phenylbenzimidazoler og 2-phenylindoler, fremstilling af anvendelse heraf
NO20020571D0 (no) Peptider som blokkerer virusinfeksjonsevnen og fremgangsmåter for anvendelse av disse
NO910381L (no) Fremgangsmaate ved sammenfoeyning av konstruksjonselementer.
DK1109450T3 (da) Mikrokapselpræparater
NL1003765A1 (nl) Opvoedkundige inrichting.
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
ATE298576T1 (de) Arzneizubereitungen
NO20004349D0 (no) Metoder og anordninger for modulering av immunresponsen
AU7471098A (en) Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents
EE9900455A (et) Uus menetlus
DK1027558T3 (da) Sikkerhedsafbrydeanordning
NL300165I2 (nl) Babesiavaccin.
ATE431415T1 (de) Hiv impfstoff

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application